Haura EB - Search Results

1

Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors.

Bai Y, Li J, Fang B, Edwards A, Zhang G, Bui M, Eschrich S, Altiok S, Koomen J, Haura EB. Bai Y, et al. Among authors: haura eb. Cancer Res. 2012 May 15;72(10):2501-11. doi: 10.1158/0008-5472.CAN-11-3015. Epub 2012 Mar 29. Cancer Res. 2012. PMID: 22461510 Free PMC article.

2

Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.

Song L, Turkson J, Karras JG, Jove R, Haura EB. Song L, et al. Among authors: haura eb. Oncogene. 2003 Jul 3;22(27):4150-65. doi: 10.1038/sj.onc.1206479. Oncogene. 2003. PMID: 12833138

3

Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity.

Turkson J, Kim JS, Zhang S, Yuan J, Huang M, Glenn M, Haura E, Sebti S, Hamilton AD, Jove R. Turkson J, et al. Mol Cancer Ther. 2004 Mar;3(3):261-9. Mol Cancer Ther. 2004. PMID: 15026546

4

Mcl-1 regulates survival and sensitivity to diverse apoptotic stimuli in human non-small cell lung cancer cells.

Song L, Coppola D, Livingston S, Cress D, Haura EB. Song L, et al. Among authors: haura eb. Cancer Biol Ther. 2005 Mar;4(3):267-76. doi: 10.4161/cbt.4.3.1496. Epub 2005 Mar 20. Cancer Biol Ther. 2005. PMID: 15753661 Free article.

5

Activated epidermal growth factor receptor-Stat-3 signaling promotes tumor survival in vivo in non-small cell lung cancer.

Haura EB, Zheng Z, Song L, Cantor A, Bepler G. Haura EB, et al. Clin Cancer Res. 2005 Dec 1;11(23):8288-94. doi: 10.1158/1078-0432.CCR-05-0827. Clin Cancer Res. 2005. PMID: 16322287

6

Autocrine interleukin-6/interleukin-6 receptor stimulation in non-small-cell lung cancer.

Haura EB, Livingston S, Coppola D. Haura EB, et al. Clin Lung Cancer. 2006 Jan;7(4):273-5. doi: 10.3816/CLC.2006.n.006. Clin Lung Cancer. 2006. PMID: 16512982

7

Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival.

Song L, Morris M, Bagui T, Lee FY, Jove R, Haura EB. Song L, et al. Among authors: haura eb. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620. Cancer Res. 2006. PMID: 16740687

8

Effects of IFN-gamma and Stat1 on gene expression, growth, and survival in non-small cell lung cancer cells.

Li J, Yu B, Song L, Eschrich S, Haura EB. Li J, et al. Among authors: haura eb. J Interferon Cytokine Res. 2007 Mar;27(3):209-20. doi: 10.1089/jir.2006.0111. J Interferon Cytokine Res. 2007. PMID: 17348819

9

A small molecule pan-Bcl-2 family inhibitor, GX15-070, induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer cells.

Li J, Viallet J, Haura EB. Li J, et al. Among authors: haura eb. Cancer Chemother Pharmacol. 2008 Mar;61(3):525-34. doi: 10.1007/s00280-007-0499-3. Epub 2007 May 16. Cancer Chemother Pharmacol. 2008. PMID: 17505826

10

Effect of the histone deacetylase inhibitor LBH589 against epidermal growth factor receptor-dependent human lung cancer cells.

Edwards A, Li J, Atadja P, Bhalla K, Haura EB. Edwards A, et al. Among authors: haura eb. Mol Cancer Ther. 2007 Sep;6(9):2515-24. doi: 10.1158/1535-7163.MCT-06-0761. Mol Cancer Ther. 2007. PMID: 17876048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

245 results

Search Page

Filters